Brief: Novabay Pharmaceuticals Got Notice From NYSE American Stating Co Is Below Compliance With NYSE American Continued Listing Standards
19/04/2024 23:24
April 19 (Reuters) - NovaBay Pharmaceuticals Inc
NBY.A :
* NOVABAY PHARMACEUTICALS: ON APRIL 18, GOT NOTICE FROM NYSE
AMERICAN STATING CO IS BELOW COMPLIANCE WITH NYSE AMERICAN
CONTINUED LISTING STANDARDS
Further company coverage: NBY.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Stablecoin Development
See all newsBrief: Stablecoin Development Corporation Reports First Quarter 2026 Financial Results
Brief: Tether Says Participated In A $134 Million Financing Round For Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Announces Name Change To Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Says David Lazar Resigns As CEO
Brief: NovaBay Pharmaceuticals Files For Mixed Shelf Of Up To $200 Million - SEC Filing